APO Research
Talk to an analyst

APO RESEARCH · REPORT

Orthobiologics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Orthobiologics Market Analysis and Forecast 2026-2032

21 December 2025202 pages

Choose your research edition.

Industry ResearchOrthobiologics Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Orthobiologics Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Orthobiologics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orthobiologics Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Orthobiologics Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Orthobiologics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Orthobiologics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Orthobiologics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Orthobiologics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Orthobiologics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Orthobiologics include Stryker Corporation, Sanofi-Aventis (Sanofi SA), Medtronic, Zimmer Biomet Holdings, TRB Chemedica International SA, Seikagaku Corporation, SeaSpine Holdings Corporation, RTI Surgical, Inc. and Orthofix International N.V., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Orthobiologics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Orthobiologics, also provides the sales of main regions and countries. Of the upcoming market potential for Orthobiologics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Orthobiologics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Orthobiologics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Orthobiologics sales, projected growth trends, production technology, application and end-user industry.

Orthobiologics Segment by Company

Stryker Corporation

Sanofi-Aventis (Sanofi SA)

Medtronic

Zimmer Biomet Holdings

TRB Chemedica International SA

Seikagaku Corporation

SeaSpine Holdings Corporation

RTI Surgical, Inc.

Orthofix International N.V.

NuVasive, Inc.

Musculoskeletal Transplant Foundation, Inc.

Ito

Heraeus Holding GmbH

Fidia Pharma USA Inc.

Djo Global, Inc.

DePuy Synthes (Johnson & Johnson)

Bioventus

Arthrex, Inc.

Anika Therapeutics, Inc.

Allosource

Orthobiologics Segment by Type

Viscosupplements

Bone Graft Substitute

Bone Growth Stimulators (BGS)

Orthobiologics Segment by Application

Hospitals

Ambulatory Surgical Centres

Orthopaedics Clinics

Orthobiologics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orthobiologics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orthobiologics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orthobiologics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Orthobiologics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Orthobiologics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Orthobiologics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Orthobiologics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Viscosupplements Major Manufacturers Table 3. Bone Graft Substitute Major Manufacturers Table 4. Bone Growth Stimulators (BGS) Major Manufacturers Table 5. Global Orthobiologics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Manufacturers Table 7. Ambulatory Surgical Centres Major Manufacturers Table 8. Orthopaedics Clinics Major Manufacturers Table 9. Orthobiologics Industry Trends Table 10. Orthobiologics Industry Drivers Table 11. Orthobiologics Industry Opportunities and Challenges Table 12. Orthobiologics Industry Restraints Table 13. Global Orthobiologics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Orthobiologics Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Orthobiologics Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Orthobiologics Revenue Market Share by Region (2021-2026) Table 17. Global Orthobiologics Revenue Market Share by Region (2027-2032) Table 18. Global Orthobiologics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Orthobiologics Sales by Region (2021-2026) & (k units) Table 20. Global Orthobiologics Sales by Region (2027-2032) & (k units) Table 21. Global Orthobiologics Sales Market Share by Region (2021-2026) Table 22. Global Orthobiologics Sales Market Share by Region (2027-2032) Table 23. Global Orthobiologics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Orthobiologics Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Orthobiologics Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Orthobiologics Sales Market Share by Manufacturers (2021-2026) Table 27. Global Orthobiologics Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Orthobiologics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Orthobiologics Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Orthobiologics Manufacturers, Product Type & Application Table 31. Global Orthobiologics Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Orthobiologics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Orthobiologics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Orthobiologics Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Orthobiologics Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Orthobiologics Revenue Market Share by Type (2021-2026) Table 38. Global Orthobiologics Revenue Market Share by Type (2027-2032) Table 39. Global Orthobiologics Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Orthobiologics Sales by Type (2021-2026) & (k units) Table 41. Global Orthobiologics Sales by Type (2027-2032) & (k units) Table 42. Global Orthobiologics Sales Market Share by Type (2021-2026) Table 43. Global Orthobiologics Sales Market Share by Type (2027-2032) Table 44. Global Orthobiologics Price by Type (2021-2026) & (US$/unit) Table 45. Global Orthobiologics Price by Type (2027-2032) & (US$/unit) Table 46. Global Orthobiologics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Orthobiologics Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Orthobiologics Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Orthobiologics Revenue Market Share by Application (2021-2026) Table 50. Global Orthobiologics Revenue Market Share by Application (2027-2032) Table 51. Global Orthobiologics Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Orthobiologics Sales by Application (2021-2026) & (k units) Table 53. Global Orthobiologics Sales by Application (2027-2032) & (k units) Table 54. Global Orthobiologics Sales Market Share by Application (2021-2026) Table 55. Global Orthobiologics Sales Market Share by Application (2027-2032) Table 56. Global Orthobiologics Price by Application (2021-2026) & (US$/unit) Table 57. Global Orthobiologics Price by Application (2027-2032) & (US$/unit) Table 58. Stryker Corporation Company Information Table 59. Stryker Corporation Business Overview Table 60. Stryker Corporation Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Stryker Corporation Orthobiologics Product Portfolio Table 62. Stryker Corporation Recent Development Table 63. Sanofi-Aventis (Sanofi SA) Company Information Table 64. Sanofi-Aventis (Sanofi SA) Business Overview Table 65. Sanofi-Aventis (Sanofi SA) Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Sanofi-Aventis (Sanofi SA) Orthobiologics Product Portfolio Table 67. Sanofi-Aventis (Sanofi SA) Recent Development Table 68. Medtronic Company Information Table 69. Medtronic Business Overview Table 70. Medtronic Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Medtronic Orthobiologics Product Portfolio Table 72. Medtronic Recent Development Table 73. Zimmer Biomet Holdings Company Information Table 74. Zimmer Biomet Holdings Business Overview Table 75. Zimmer Biomet Holdings Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Zimmer Biomet Holdings Orthobiologics Product Portfolio Table 77. Zimmer Biomet Holdings Recent Development Table 78. TRB Chemedica International SA Company Information Table 79. TRB Chemedica International SA Business Overview Table 80. TRB Chemedica International SA Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. TRB Chemedica International SA Orthobiologics Product Portfolio Table 82. TRB Chemedica International SA Recent Development Table 83. Seikagaku Corporation Company Information Table 84. Seikagaku Corporation Business Overview Table 85. Seikagaku Corporation Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Seikagaku Corporation Orthobiologics Product Portfolio Table 87. Seikagaku Corporation Recent Development Table 88. SeaSpine Holdings Corporation Company Information Table 89. SeaSpine Holdings Corporation Business Overview Table 90. SeaSpine Holdings Corporation Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. SeaSpine Holdings Corporation Orthobiologics Product Portfolio Table 92. SeaSpine Holdings Corporation Recent Development Table 93. RTI Surgical, Inc. Company Information Table 94. RTI Surgical, Inc. Business Overview Table 95. RTI Surgical, Inc. Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. RTI Surgical, Inc. Orthobiologics Product Portfolio Table 97. RTI Surgical, Inc. Recent Development Table 98. Orthofix International N.V. Company Information Table 99. Orthofix International N.V. Business Overview Table 100. Orthofix International N.V. Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Orthofix International N.V. Orthobiologics Product Portfolio Table 102. Orthofix International N.V. Recent Development Table 103. NuVasive, Inc. Company Information Table 104. NuVasive, Inc. Business Overview Table 105. NuVasive, Inc. Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. NuVasive, Inc. Orthobiologics Product Portfolio Table 107. NuVasive, Inc. Recent Development Table 108. Musculoskeletal Transplant Foundation, Inc. Company Information Table 109. Musculoskeletal Transplant Foundation, Inc. Business Overview Table 110. Musculoskeletal Transplant Foundation, Inc. Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Musculoskeletal Transplant Foundation, Inc. Orthobiologics Product Portfolio Table 112. Musculoskeletal Transplant Foundation, Inc. Recent Development Table 113. Ito Company Information Table 114. Ito Business Overview Table 115. Ito Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Ito Orthobiologics Product Portfolio Table 117. Ito Recent Development Table 118. Heraeus Holding GmbH Company Information Table 119. Heraeus Holding GmbH Business Overview Table 120. Heraeus Holding GmbH Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Heraeus Holding GmbH Orthobiologics Product Portfolio Table 122. Heraeus Holding GmbH Recent Development Table 123. Fidia Pharma USA Inc. Company Information Table 124. Fidia Pharma USA Inc. Business Overview Table 125. Fidia Pharma USA Inc. Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Fidia Pharma USA Inc. Orthobiologics Product Portfolio Table 127. Fidia Pharma USA Inc. Recent Development Table 128. Djo Global, Inc. Company Information Table 129. Djo Global, Inc. Business Overview Table 130. Djo Global, Inc. Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Djo Global, Inc. Orthobiologics Product Portfolio Table 132. Djo Global, Inc. Recent Development Table 133. DePuy Synthes (Johnson & Johnson) Company Information Table 134. DePuy Synthes (Johnson & Johnson) Business Overview Table 135. DePuy Synthes (Johnson & Johnson) Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. DePuy Synthes (Johnson & Johnson) Orthobiologics Product Portfolio Table 137. DePuy Synthes (Johnson & Johnson) Recent Development Table 138. Bioventus Company Information Table 139. Bioventus Business Overview Table 140. Bioventus Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. Bioventus Orthobiologics Product Portfolio Table 142. Bioventus Recent Development Table 143. Arthrex, Inc. Company Information Table 144. Arthrex, Inc. Business Overview Table 145. Arthrex, Inc. Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. Arthrex, Inc. Orthobiologics Product Portfolio Table 147. Arthrex, Inc. Recent Development Table 148. Anika Therapeutics, Inc. Company Information Table 149. Anika Therapeutics, Inc. Business Overview Table 150. Anika Therapeutics, Inc. Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 151. Anika Therapeutics, Inc. Orthobiologics Product Portfolio Table 152. Anika Therapeutics, Inc. Recent Development Table 153. Allosource Company Information Table 154. Allosource Business Overview Table 155. Allosource Orthobiologics Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 156. Allosource Orthobiologics Product Portfolio Table 157. Allosource Recent Development Table 158. North America Orthobiologics Revenue by Type (2021-2026) & (US$ Million) Table 159. North America Orthobiologics Revenue by Type (2027-2032) & (US$ Million) Table 160. North America Orthobiologics Sales by Type (2021-2026) & (k units) Table 161. North America Orthobiologics Sales by Type (2027-2032) & (k units) Table 162. North America Orthobiologics Sales Price by Type (2021-2026) & (US$/unit) Table 163. North America Orthobiologics Sales Price by Type (2027-2032) & (US$/unit) Table 164. North America Orthobiologics Revenue by Application (2021-2026) & (US$ Million) Table 165. North America Orthobiologics Revenue by Application (2027-2032) & (US$ Million) Table 166. North America Orthobiologics Sales by Application (2021-2026) & (k units) Table 167. North America Orthobiologics Sales by Application (2027-2032) & (k units) Table 168. North America Orthobiologics Sales Price by Application (2021-2026) & (US$/unit) Table 169. North America Orthobiologics Sales Price by Application (2027-2032) & (US$/unit) Table 170. North America Orthobiologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. North America Orthobiologics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. North America Orthobiologics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. North America Orthobiologics Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 174. North America Orthobiologics Sales by Country (2021-2026) & (k units) Table 175. North America Orthobiologics Sales by Country (2027-2032) & (k units) Table 176. North America Orthobiologics Sales Price by Country (2021-2026) & (US$/unit) Table 177. North America Orthobiologics Sales Price by Country (2027-2032) & (US$/unit) Table 178. United States Orthobiologics Revenue (2021-2032) & (US$ Million) Table 179. Canada Orthobiologics Revenue (2021-2032) & (US$ Million) Table 180. Mexico Orthobiologics Revenue (2021-2032) & (US$ Million) Table 181. Europe Orthobiologics Revenue by Type (2021-2026) & (US$ Million) Table 182. Europe Orthobiologics Revenue by Type (2027-2032) & (US$ Million) Table 183. Europe Orthobiologics Sales by Type (2021-2026) & (k units) Table 184. Europe Orthobiologics Sales by Type (2027-2032) & (k units) Table 185. Europe Orthobiologics Sales Price by Type (2021-2026) & (US$/unit) Table 186. Europe Orthobiologics Sales Price by Type (2027-2032) & (US$/unit) Table 187. Europe Orthobiologics Revenue by Application (2021-2026) & (US$ Million) Table 188. Europe Orthobiologics Revenue by Application (2027-2032) & (US$ Million) Table 189. Europe Orthobiologics Sales by Application (2021-2026) & (k units) Table 190. Europe Orthobiologics Sales by Application (2027-2032) & (k units) Table 191. Europe Orthobiologics Sales Price by Application (2021-2026) & (US$/unit) Table 192. Europe Orthobiologics Sales Price by Application (2027-2032) & (US$/unit) Table 193. Europe Orthobiologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Europe Orthobiologics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Europe Orthobiologics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Europe Orthobiologics Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 197. Europe Orthobiologics Sales by Country (2021-2026) & (k units) Table 198. Europe Orthobiologics Sales by Country (2027-2032) & (k units) Table 199. Europe Orthobiologics Sales Price by Country (2021-2026) & (US$/unit) Table 200. Europe Orthobiologics Sales Price by Country (2027-2032) & (US$/unit) Table 201. Germany Orthobiologics Revenue (2021-2032) & (US$ Million) Table 202. France Orthobiologics Revenue (2021-2032) & (US$ Million) Table 203. U.K. Orthobiologics Revenue (2021-2032) & (US$ Million) Table 204. Italy Orthobiologics Revenue (2021-2032) & (US$ Million) Table 205. Russia Orthobiologics Revenue (2021-2032) & (US$ Million) Table 206. Spain Orthobiologics Revenue (2021-2032) & (US$ Million) Table 207. Netherlands Orthobiologics Revenue (2021-2032) & (US$ Million) Table 208. Switzerland Orthobiologics Revenue (2021-2032) & (US$ Million) Table 209. Sweden Orthobiologics Revenue (2021-2032) & (US$ Million) Table 210. Poland Orthobiologics Revenue (2021-2032) & (US$ Million) Table 211. China Orthobiologics Revenue by Type (2021-2026) & (US$ Million) Table 212. China Orthobiologics Revenue by Type (2027-2032) & (US$ Million) Table 213. China Orthobiologics Sales by Type (2021-2026) & (k units) Table 214. China Orthobiologics Sales by Type (2027-2032) & (k units) Table 215. China Orthobiologics Sales Price by Type (2021-2026) & (US$/unit) Table 216. China Orthobiologics Sales Price by Type (2027-2032) & (US$/unit) Table 217. China Orthobiologics Revenue by Application (2021-2026) & (US$ Million) Table 218. China Orthobiologics Revenue by Application (2027-2032) & (US$ Million) Table 219. China Orthobiologics Sales by Application (2021-2026) & (k units) Table 220. China Orthobiologics Sales by Application (2027-2032) & (k units) Table 221. China Orthobiologics Sales Price by Application (2021-2026) & (US$/unit) Table 222. China Orthobiologics Sales Price by Application (2027-2032) & (US$/unit) Table 223. Asia Orthobiologics Revenue by Type (2021-2026) & (US$ Million) Table 224. Asia Orthobiologics Revenue by Type (2027-2032) & (US$ Million) Table 225. Asia Orthobiologics Sales by Type (2021-2026) & (k units) Table 226. Asia Orthobiologics Sales by Type (2027-2032) & (k units) Table 227. Asia Orthobiologics Sales Price by Type (2021-2026) & (US$/unit) Table 228. Asia Orthobiologics Sales Price by Type (2027-2032) & (US$/unit) Table 229. Asia Orthobiologics Revenue by Application (2021-2026) & (US$ Million) Table 230. Asia Orthobiologics Revenue by Application (2027-2032) & (US$ Million) Table 231. Asia Orthobiologics Sales by Application (2021-2026) & (k units) Table 232. Asia Orthobiologics Sales by Application (2027-2032) & (k units) Table 233. Asia Orthobiologics Sales Price by Application (2021-2026) & (US$/unit) Table 234. Asia Orthobiologics Sales Price by Application (2027-2032) & (US$/unit) Table 235. Asia Orthobiologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. Asia Orthobiologics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. Asia Orthobiologics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. Asia Orthobiologics Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 239. Asia Orthobiologics Sales by Country (2021-2026) & (k units) Table 240. Asia Orthobiologics Sales by Country (2027-2032) & (k units) Table 241. Asia Orthobiologics Sales Price by Country (2021-2026) & (US$/unit) Table 242. Asia Orthobiologics Sales Price by Country (2027-2032) & (US$/unit) Table 243. Japan Orthobiologics Revenue (2021-2032) & (US$ Million) Table 244. South Korea Orthobiologics Revenue (2021-2032) & (US$ Million) Table 245. India Orthobiologics Revenue (2021-2032) & (US$ Million) Table 246. Australia Orthobiologics Revenue (2021-2032) & (US$ Million) Table 247. Taiwan Orthobiologics Revenue (2021-2032) & (US$ Million) Table 248. Southeast Asia Orthobiologics Revenue (2021-2032) & (US$ Million) Table 249. SAMEA Orthobiologics Revenue by Type (2021-2026) & (US$ Million) Table 250. SAMEA Orthobiologics Revenue by Type (2027-2032) & (US$ Million) Table 251. SAMEA Orthobiologics Sales by Type (2021-2026) & (k units) Table 252. SAMEA Orthobiologics Sales by Type (2027-2032) & (k units) Table 253. SAMEA Orthobiologics Sales Price by Type (2021-2026) & (US$/unit) Table 254. SAMEA Orthobiologics Sales Price by Type (2027-2032) & (US$/unit) Table 255. SAMEA Orthobiologics Revenue by Application (2021-2026) & (US$ Million) Table 256. SAMEA Orthobiologics Revenue by Application (2027-2032) & (US$ Million) Table 257. SAMEA Orthobiologics Sales by Application (2021-2026) & (k units) Table 258. SAMEA Orthobiologics Sales by Application (2027-2032) & (k units) Table 259. SAMEA Orthobiologics Sales Price by Application (2021-2026) & (US$/unit) Table 260. SAMEA Orthobiologics Sales Price by Application (2027-2032) & (US$/unit) Table 261. SAMEA Orthobiologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 262. SAMEA Orthobiologics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 263. SAMEA Orthobiologics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 264. SAMEA Orthobiologics Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 265. SAMEA Orthobiologics Sales by Country (2021-2026) & (k units) Table 266. SAMEA Orthobiologics Sales by Country (2027-2032) & (k units) Table 267. SAMEA Orthobiologics Sales Price by Country (2021-2026) & (US$/unit) Table 268. SAMEA Orthobiologics Sales Price by Country (2027-2032) & (US$/unit) Table 269. Brazil Orthobiologics Revenue (2021-2032) & (US$ Million) Table 270. Argentina Orthobiologics Revenue (2021-2032) & (US$ Million) Table 271. Chile Orthobiologics Revenue (2021-2032) & (US$ Million) Table 272. Colombia Orthobiologics Revenue (2021-2032) & (US$ Million) Table 273. Peru Orthobiologics Revenue (2021-2032) & (US$ Million) Table 274. Saudi Arabia Orthobiologics Revenue (2021-2032) & (US$ Million) Table 275. Israel Orthobiologics Revenue (2021-2032) & (US$ Million) Table 276. UAE Orthobiologics Revenue (2021-2032) & (US$ Million) Table 277. Turkey Orthobiologics Revenue (2021-2032) & (US$ Million) Table 278. Iran Orthobiologics Revenue (2021-2032) & (US$ Million) Table 279. Egypt Orthobiologics Revenue (2021-2032) & (US$ Million) Table 280. Key Raw Materials Table 281. Raw Materials Key Suppliers Table 282. Orthobiologics Distributors List Table 283. Orthobiologics Customers List Table 284. Research Programs/Design for This Report Table 285. Authors List of This Report Table 286. Secondary Sources Table 287. Primary Sources List of Figures Figure 1. Orthobiologics Image Figure 2. Global Orthobiologics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Orthobiologics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Viscosupplements Image Figure 5. Bone Graft Substitute Image Figure 6. Bone Growth Stimulators (BGS) Image Figure 7. Global Orthobiologics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Orthobiologics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Ambulatory Surgical Centres Image Figure 11. Orthopaedics Clinics Image Figure 12. Global Orthobiologics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Orthobiologics Revenue (2021-2032) & (US$ Million) Figure 14. Global Orthobiologics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Orthobiologics Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Orthobiologics Revenue Market Share by Region (2021-2032) Figure 17. Global Orthobiologics Sales (2021-2032) & (k units) Figure 18. Global Orthobiologics Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Orthobiologics Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Orthobiologics Sales YoY (2021-2032) & (k units) Figure 21. Europe Orthobiologics Sales YoY (2021-2032) & (k units) Figure 22. China Orthobiologics Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Orthobiologics Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Orthobiologics Sales YoY (2021-2032) & (k units) Figure 25. Global Orthobiologics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Orthobiologics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Orthobiologics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Orthobiologics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Orthobiologics Revenue Market Share by Type (2021-2032) Figure 31. Global Orthobiologics Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Orthobiologics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Orthobiologics Sales Market Share by Type (2021-2032) Figure 34. Global Orthobiologics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Orthobiologics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Orthobiologics Revenue Market Share by Application (2021-2032) Figure 37. Global Orthobiologics Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Orthobiologics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Orthobiologics Sales Market Share by Application (2021-2032) Figure 40. North America Orthobiologics Revenue Share by Type (2021-2032) Figure 41. North America Orthobiologics Sales Share by Type (2021-2032) Figure 42. North America Orthobiologics Revenue Share by Application (2021-2032) Figure 43. North America Orthobiologics Sales Share by Application (2021-2032) Figure 44. North America Orthobiologics Revenue Share by Country (2021-2032) Figure 45. North America Orthobiologics Sales Share by Country (2021-2032) Figure 46. Europe Orthobiologics Revenue Share by Type (2021-2032) Figure 47. Europe Orthobiologics Sales Share by Type (2021-2032) Figure 48. Europe Orthobiologics Revenue Share by Application (2021-2032) Figure 49. Europe Orthobiologics Sales Share by Application (2021-2032) Figure 50. Europe Orthobiologics Revenue Share by Country (2021-2032) Figure 51. Europe Orthobiologics Sales Share by Country (2021-2032) Figure 52. China Orthobiologics Revenue Share by Type (2021-2032) Figure 53. China Orthobiologics Sales Share by Type (2021-2032) Figure 54. China Orthobiologics Revenue Share by Application (2021-2032) Figure 55. China Orthobiologics Sales Share by Application (2021-2032) Figure 56. Asia Orthobiologics Revenue Share by Type (2021-2032) Figure 57. Asia Orthobiologics Sales Share by Type (2021-2032) Figure 58. Asia Orthobiologics Revenue Share by Application (2021-2032) Figure 59. Asia Orthobiologics Sales Share by Application (2021-2032) Figure 60. Asia Orthobiologics Revenue Share by Country (2021-2032) Figure 61. Asia Orthobiologics Sales Share by Country (2021-2032) Figure 62. SAMEA Orthobiologics Revenue Share by Type (2021-2032) Figure 63. SAMEA Orthobiologics Sales Share by Type (2021-2032) Figure 64. SAMEA Orthobiologics Revenue Share by Application (2021-2032) Figure 65. SAMEA Orthobiologics Sales Share by Application (2021-2032) Figure 66. SAMEA Orthobiologics Revenue Share by Country (2021-2032) Figure 67. SAMEA Orthobiologics Sales Share by Country (2021-2032) Figure 68. Orthobiologics Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Orthobiologics Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Viscosupplements
  • Bone Graft Substitute
  • Bone Growth Stimulators (BGS)
Applications
  • Hospitals
  • Ambulatory Surgical Centres
  • Orthopaedics Clinics
Companies covered
  • Stryker Corporation
  • Sanofi-Aventis (Sanofi SA)
  • Medtronic
  • Zimmer Biomet Holdings
  • TRB Chemedica International SA
  • Seikagaku Corporation
  • SeaSpine Holdings Corporation
  • RTI Surgical, Inc.
  • Orthofix International N.V.
  • NuVasive, Inc.
  • Musculoskeletal Transplant Foundation, Inc.
  • Ito
  • Heraeus Holding GmbH
  • Fidia Pharma USA Inc.
  • Djo Global, Inc.
  • DePuy Synthes (Johnson & Johnson)
  • Bioventus
  • Arthrex, Inc.
  • Anika Therapeutics, Inc.
  • Allosource

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Orthobiologics Market by Type
  3. 1.2.1 Global Orthobiologics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Viscosupplements
  5. 1.2.3 Bone Graft Substitute
  6. 1.2.4 Bone Growth Stimulators (BGS)
  7. 1.3 Orthobiologics Market by Application
  8. 1.3.1 Global Orthobiologics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Ambulatory Surgical Centres
  11. 1.3.4 Orthopaedics Clinics
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Orthobiologics Market Dynamics
  1. 2.1 Orthobiologics Industry Trends
  2. 2.2 Orthobiologics Industry Drivers
  3. 2.3 Orthobiologics Industry Opportunities and Challenges
  4. 2.4 Orthobiologics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Orthobiologics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Orthobiologics Revenue by Region
  3. 3.2.1 Global Orthobiologics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Orthobiologics Revenue by Region (2021-2026)
  5. 3.2.3 Global Orthobiologics Revenue by Region (2027-2032)
  6. 3.2.4 Global Orthobiologics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Orthobiologics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Orthobiologics Sales by Region
  9. 3.4.1 Global Orthobiologics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Orthobiologics Sales by Region (2021-2026)
  11. 3.4.3 Global Orthobiologics Sales by Region (2027-2032)
  12. 3.4.4 Global Orthobiologics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Orthobiologics Revenue by Manufacturers
  2. 4.1.1 Global Orthobiologics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Orthobiologics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Orthobiologics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Orthobiologics Sales by Manufacturers
  6. 4.2.1 Global Orthobiologics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Orthobiologics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Orthobiologics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Orthobiologics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Orthobiologics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Orthobiologics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Orthobiologics Manufacturers, Product Type & Application
  13. 4.7 Global Orthobiologics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Orthobiologics Market CR5 and HHI
  16. 4.8.2 2025 Orthobiologics Tier 1, Tier 2, and Tier 3
5 Orthobiologics Market by Type
  1. 5.1 Global Orthobiologics Revenue by Type
  2. 5.1.1 Global Orthobiologics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Orthobiologics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Orthobiologics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Orthobiologics Sales by Type
  6. 5.2.1 Global Orthobiologics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Orthobiologics Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Orthobiologics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Orthobiologics Price by Type
6 Orthobiologics Market by Application
  1. 6.1 Global Orthobiologics Revenue by Application
  2. 6.1.1 Global Orthobiologics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Orthobiologics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Orthobiologics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Orthobiologics Sales by Application
  6. 6.2.1 Global Orthobiologics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Orthobiologics Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Orthobiologics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Orthobiologics Price by Application
7 Company Profiles
  1. 7.1 Stryker Corporation
  2. 7.1.1 Stryker Corporation Company Information
  3. 7.1.2 Stryker Corporation Business Overview
  4. 7.1.3 Stryker Corporation Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Stryker Corporation Orthobiologics Product Portfolio
  6. 7.1.5 Stryker Corporation Recent Developments
  7. 7.2 Sanofi-Aventis (Sanofi SA)
  8. 7.2.1 Sanofi-Aventis (Sanofi SA) Company Information
  9. 7.2.2 Sanofi-Aventis (Sanofi SA) Business Overview
  10. 7.2.3 Sanofi-Aventis (Sanofi SA) Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi-Aventis (Sanofi SA) Orthobiologics Product Portfolio
  12. 7.2.5 Sanofi-Aventis (Sanofi SA) Recent Developments
  13. 7.3 Medtronic
  14. 7.3.1 Medtronic Company Information
  15. 7.3.2 Medtronic Business Overview
  16. 7.3.3 Medtronic Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Medtronic Orthobiologics Product Portfolio
  18. 7.3.5 Medtronic Recent Developments
  19. 7.4 Zimmer Biomet Holdings
  20. 7.4.1 Zimmer Biomet Holdings Company Information
  21. 7.4.2 Zimmer Biomet Holdings Business Overview
  22. 7.4.3 Zimmer Biomet Holdings Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Zimmer Biomet Holdings Orthobiologics Product Portfolio
  24. 7.4.5 Zimmer Biomet Holdings Recent Developments
  25. 7.5 TRB Chemedica International SA
  26. 7.5.1 TRB Chemedica International SA Company Information
  27. 7.5.2 TRB Chemedica International SA Business Overview
  28. 7.5.3 TRB Chemedica International SA Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 TRB Chemedica International SA Orthobiologics Product Portfolio
  30. 7.5.5 TRB Chemedica International SA Recent Developments
  31. 7.6 Seikagaku Corporation
  32. 7.6.1 Seikagaku Corporation Company Information
  33. 7.6.2 Seikagaku Corporation Business Overview
  34. 7.6.3 Seikagaku Corporation Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Seikagaku Corporation Orthobiologics Product Portfolio
  36. 7.6.5 Seikagaku Corporation Recent Developments
  37. 7.7 SeaSpine Holdings Corporation
  38. 7.7.1 SeaSpine Holdings Corporation Company Information
  39. 7.7.2 SeaSpine Holdings Corporation Business Overview
  40. 7.7.3 SeaSpine Holdings Corporation Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 SeaSpine Holdings Corporation Orthobiologics Product Portfolio
  42. 7.7.5 SeaSpine Holdings Corporation Recent Developments
  43. 7.8 RTI Surgical, Inc.
  44. 7.8.1 RTI Surgical, Inc. Company Information
  45. 7.8.2 RTI Surgical, Inc. Business Overview
  46. 7.8.3 RTI Surgical, Inc. Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 RTI Surgical, Inc. Orthobiologics Product Portfolio
  48. 7.8.5 RTI Surgical, Inc. Recent Developments
  49. 7.9 Orthofix International N.V.
  50. 7.9.1 Orthofix International N.V. Company Information
  51. 7.9.2 Orthofix International N.V. Business Overview
  52. 7.9.3 Orthofix International N.V. Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Orthofix International N.V. Orthobiologics Product Portfolio
  54. 7.9.5 Orthofix International N.V. Recent Developments
  55. 7.10 NuVasive, Inc.
  56. 7.10.1 NuVasive, Inc. Company Information
  57. 7.10.2 NuVasive, Inc. Business Overview
  58. 7.10.3 NuVasive, Inc. Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 NuVasive, Inc. Orthobiologics Product Portfolio
  60. 7.10.5 NuVasive, Inc. Recent Developments
  61. 7.11 Musculoskeletal Transplant Foundation, Inc.
  62. 7.11.1 Musculoskeletal Transplant Foundation, Inc. Company Information
  63. 7.11.2 Musculoskeletal Transplant Foundation, Inc. Business Overview
  64. 7.11.3 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Musculoskeletal Transplant Foundation, Inc. Orthobiologics Product Portfolio
  66. 7.11.5 Musculoskeletal Transplant Foundation, Inc. Recent Developments
  67. 7.12 Ito
  68. 7.12.1 Ito Company Information
  69. 7.12.2 Ito Business Overview
  70. 7.12.3 Ito Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Ito Orthobiologics Product Portfolio
  72. 7.12.5 Ito Recent Developments
  73. 7.13 Heraeus Holding GmbH
  74. 7.13.1 Heraeus Holding GmbH Company Information
  75. 7.13.2 Heraeus Holding GmbH Business Overview
  76. 7.13.3 Heraeus Holding GmbH Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Heraeus Holding GmbH Orthobiologics Product Portfolio
  78. 7.13.5 Heraeus Holding GmbH Recent Developments
  79. 7.14 Fidia Pharma USA Inc.
  80. 7.14.1 Fidia Pharma USA Inc. Company Information
  81. 7.14.2 Fidia Pharma USA Inc. Business Overview
  82. 7.14.3 Fidia Pharma USA Inc. Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Fidia Pharma USA Inc. Orthobiologics Product Portfolio
  84. 7.14.5 Fidia Pharma USA Inc. Recent Developments
  85. 7.15 Djo Global, Inc.
  86. 7.15.1 Djo Global, Inc. Company Information
  87. 7.15.2 Djo Global, Inc. Business Overview
  88. 7.15.3 Djo Global, Inc. Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Djo Global, Inc. Orthobiologics Product Portfolio
  90. 7.15.5 Djo Global, Inc. Recent Developments
  91. 7.16 DePuy Synthes (Johnson & Johnson)
  92. 7.16.1 DePuy Synthes (Johnson & Johnson) Company Information
  93. 7.16.2 DePuy Synthes (Johnson & Johnson) Business Overview
  94. 7.16.3 DePuy Synthes (Johnson & Johnson) Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 DePuy Synthes (Johnson & Johnson) Orthobiologics Product Portfolio
  96. 7.16.5 DePuy Synthes (Johnson & Johnson) Recent Developments
  97. 7.17 Bioventus
  98. 7.17.1 Bioventus Company Information
  99. 7.17.2 Bioventus Business Overview
  100. 7.17.3 Bioventus Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Bioventus Orthobiologics Product Portfolio
  102. 7.17.5 Bioventus Recent Developments
  103. 7.18 Arthrex, Inc.
  104. 7.18.1 Arthrex, Inc. Company Information
  105. 7.18.2 Arthrex, Inc. Business Overview
  106. 7.18.3 Arthrex, Inc. Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Arthrex, Inc. Orthobiologics Product Portfolio
  108. 7.18.5 Arthrex, Inc. Recent Developments
  109. 7.19 Anika Therapeutics, Inc.
  110. 7.19.1 Anika Therapeutics, Inc. Company Information
  111. 7.19.2 Anika Therapeutics, Inc. Business Overview
  112. 7.19.3 Anika Therapeutics, Inc. Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Anika Therapeutics, Inc. Orthobiologics Product Portfolio
  114. 7.19.5 Anika Therapeutics, Inc. Recent Developments
  115. 7.20 Allosource
  116. 7.20.1 Allosource Company Information
  117. 7.20.2 Allosource Business Overview
  118. 7.20.3 Allosource Orthobiologics Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Allosource Orthobiologics Product Portfolio
  120. 7.20.5 Allosource Recent Developments
8 North America
  1. 8.1 North America Orthobiologics Market Size by Type
  2. 8.1.1 North America Orthobiologics Revenue by Type (2021-2032)
  3. 8.1.2 North America Orthobiologics Sales by Type (2021-2032)
  4. 8.1.3 North America Orthobiologics Price by Type (2021-2032)
  5. 8.2 North America Orthobiologics Market Size by Application
  6. 8.2.1 North America Orthobiologics Revenue by Application (2021-2032)
  7. 8.2.2 North America Orthobiologics Sales by Application (2021-2032)
  8. 8.2.3 North America Orthobiologics Price by Application (2021-2032)
  9. 8.3 North America Orthobiologics Market Size by Country
  10. 8.3.1 North America Orthobiologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Orthobiologics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Orthobiologics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Orthobiologics Market Size by Type
  2. 9.1.1 Europe Orthobiologics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Orthobiologics Sales by Type (2021-2032)
  4. 9.1.3 Europe Orthobiologics Price by Type (2021-2032)
  5. 9.2 Europe Orthobiologics Market Size by Application
  6. 9.2.1 Europe Orthobiologics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Orthobiologics Sales by Application (2021-2032)
  8. 9.2.3 Europe Orthobiologics Price by Application (2021-2032)
  9. 9.3 Europe Orthobiologics Market Size by Country
  10. 9.3.1 Europe Orthobiologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Orthobiologics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Orthobiologics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Orthobiologics Market Size by Type
  2. 10.1.1 China Orthobiologics Revenue by Type (2021-2032)
  3. 10.1.2 China Orthobiologics Sales by Type (2021-2032)
  4. 10.1.3 China Orthobiologics Price by Type (2021-2032)
  5. 10.2 China Orthobiologics Market Size by Application
  6. 10.2.1 China Orthobiologics Revenue by Application (2021-2032)
  7. 10.2.2 China Orthobiologics Sales by Application (2021-2032)
  8. 10.2.3 China Orthobiologics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Orthobiologics Market Size by Type
  2. 11.1.1 Asia Orthobiologics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Orthobiologics Sales by Type (2021-2032)
  4. 11.1.3 Asia Orthobiologics Price by Type (2021-2032)
  5. 11.2 Asia Orthobiologics Market Size by Application
  6. 11.2.1 Asia Orthobiologics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Orthobiologics Sales by Application (2021-2032)
  8. 11.2.3 Asia Orthobiologics Price by Application (2021-2032)
  9. 11.3 Asia Orthobiologics Market Size by Country
  10. 11.3.1 Asia Orthobiologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Orthobiologics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Orthobiologics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Orthobiologics Market Size by Type
  2. 12.1.1 SAMEA Orthobiologics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Orthobiologics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Orthobiologics Price by Type (2021-2032)
  5. 12.2 SAMEA Orthobiologics Market Size by Application
  6. 12.2.1 SAMEA Orthobiologics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Orthobiologics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Orthobiologics Price by Application (2021-2032)
  9. 12.3 SAMEA Orthobiologics Market Size by Country
  10. 12.3.1 SAMEA Orthobiologics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Orthobiologics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Orthobiologics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Orthobiologics Value Chain Analysis
  2. 13.1.1 Orthobiologics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Orthobiologics Production Mode & Process
  6. 13.2 Orthobiologics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Orthobiologics Distributors
  9. 13.2.3 Orthobiologics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst